Global CD40 Ligand Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 CD40 Ligand Industry
  • 1.1.1 Overview
  • 1.1.2 Development of CD40 Ligand
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 CD40 Ligand Market by Type

• 3.1 By Type
  • 3.1.1 ISF-35
  • 3.1.2 LOAd-700
  • 3.1.3 MEDI-4920
  • 3.1.4 MegaCD40L
  • 3.1.5 Others
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.CD40 Ligand Biogen, Inc. (Company Profile, Sales Data etc.)

• 4.2 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
• 4.3 eTheRNA Immunotherapies NV (Company Profile, Sales Data etc.)
• 4.4 ImmuNext, Inc. (Company Profile, Sales Data etc.)
• 4.5 Juno Therapeutics Inc. (Company Profile, Sales Data etc.)
• 4.6 MedImmune, LLC (Company Profile, Sales Data etc.)
• 4.7 Targovax AS (Company Profile, Sales Data etc.)
• 4.8 XL-protein GmbH (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Hepatitis B
  • 6.1.2 Demand in Bladder Cancer
  • 6.1.3 Demand in Liver Cancer
  • 6.1.4 Demand in Ovarian Cancer
  • 6.1.5 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of CD40 Ligand

Table Application Segment of CD40 Ligand

Table Global CD40 Ligand Market 2013-2024, by Application, in USD Million

Table Major Company List of ISF-35

Table Major Company List of LOAd-700

Table Major Company List of MEDI-4920

Table Major Company List of MegaCD40L

Table Major Company List of Others

Table Global CD40 Ligand Market 2013-2018, by Type, in USD Million

Table Global CD40 Ligand Market 2013-2018, by Type, in Volume

Table Global CD40 Ligand Market Forecast 2019-2024, by Type, in USD Million

Table Global CD40 Ligand Market Forecast 2019-2024, by Type, in Volume

Table Biogen, Inc. Overview List

Table CD40 Ligand Business Operation of Biogen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Company Overview List

Table CD40 Ligand Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table eTheRNA Immunotherapies NV Overview List

Table CD40 Ligand Business Operation of eTheRNA Immunotherapies NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table ImmuNext, Inc. Overview List

Table CD40 Ligand Business Operation of ImmuNext, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Juno Therapeutics Inc. Overview List

Table CD40 Ligand Business Operation of Juno Therapeutics Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table MedImmune, LLC Overview List

Table CD40 Ligand Business Operation of MedImmune, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Targovax AS Overview List

Table CD40 Ligand Business Operation of Targovax AS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table XL-protein GmbH Overview List

Table CD40 Ligand Business Operation of XL-protein GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global CD40 Ligand Sales Revenue 2013-2018, by Company, in USD Million

Table Global CD40 Ligand Sales Revenue Share, by Company, in USD Million

Table Global CD40 Ligand Sales Volume 2013-2018, by Company, in Volume

Table Global CD40 Ligand Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table CD40 Ligand Demand Forecast 2019-2024, by Application, in USD Million

Table CD40 Ligand Demand Forecast 2019-2024, by Application, in Volume

Table CD40 Ligand Production 2013-2018, by Region, in USD Million

Table CD40 Ligand Production 2013-2018, by Region, in Volume

Table Global CD40 Ligand Market 2013-2018, by Region, in USD Million

Table Global CD40 Ligand Market Share 2013-2018, by Region, in USD Million

Table Global CD40 Ligand Market 2013-2018, by Region, in Volume

Table Global CD40 Ligand Market Share 2013-2018, by Region, in Volume

Table North America CD40 Ligand Market Size 2013-2018, by Country, in USD Million

Table North America CD40 Ligand Market Size 2013-2018, by Country, in Volume

Table Europe CD40 Ligand Market Size 2013-2018, by Country, in USD Million

Table Europe CD40 Ligand Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific CD40 Ligand Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific CD40 Ligand Market Size 2013-2018, by Country, in Volume

Table South America CD40 Ligand Market Size 2013-2018, by Country, in USD Million

Table South America CD40 Ligand Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa CD40 Ligand Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa CD40 Ligand Market Size 2013-2018, by Country, in Volume

Table CD40 Ligand Market Forecast 2019-2024, by Region, in USD Million

Table CD40 Ligand Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global CD40 Ligand Market Growth 2013-2018, by Type, in USD Million

Figure Global CD40 Ligand Market Growth 2013-2018, by Type, in Volume

Figure North America CD40 Ligand Market Concentration, in 2018

Figure Europe CD40 Ligand Market Market Concentration, in 2018

Figure Asia-Pacific CD40 Ligand MMarket Concentration, in 2018

Figure South America CD40 Ligand Market Concentration, in 2018

Figure Middle East & Africa CD40 Ligand Market Concentration, in 2018

Figure CD40 Ligand Demand in Hepatitis B, 2013-2018, in USD Million

Figure CD40 Ligand Demand in Hepatitis B, 2013-2018, in Volume

Figure CD40 Ligand Demand in Bladder Cancer, 2013-2018, in USD Million

Figure CD40 Ligand Demand in Bladder Cancer, 2013-2018, in Volume

Figure CD40 Ligand Demand in Liver Cancer, 2013-2018, in USD Million

Figure CD40 Ligand Demand in Liver Cancer, 2013-2018, in Volume

Figure CD40 Ligand Demand in Ovarian Cancer, 2013-2018, in USD Million

Figure CD40 Ligand Demand in Ovarian Cancer, 2013-2018, in Volume

Figure CD40 Ligand Demand in Others, 2013-2018, in USD Million

Figure CD40 Ligand Demand in Others, 2013-2018, in Volume

Figure North America CD40 Ligand Market Size and Growth 2013-2018, in USD Million

Figure North America CD40 Ligand Market Size and Growth 2013-2018, in Volume

Figure Europe CD40 Ligand Market Size and Growth 2013-2018, in USD Million

Figure Europe CD40 Ligand Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific CD40 Ligand Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific CD40 Ligand Market Size and Growth 2013-2018, in Volume

Figure South America CD40 Ligand Market Size and Growth 2013-2018, in USD Million

Figure South America CD40 Ligand Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa CD40 Ligand Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa CD40 Ligand Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview